Invesco Biotechnology & Genome ETF
PBE
#2068
ETF rang
€0.24 Md
Capitalisation boursière
🇺🇸 US
Marché
78,66 €
Prix de l'action
-0.66%
Changement (1 jour)
44.27%
Changement (1 an)

Invesco Biotechnology & Genome ETF - Composition

Composition de l'ETF au 19 Juillet, 2026Nombre de participations : 33

Liste complète de la composition

Poids %NomSymboleActions détenues
4.98%
Vertex Pharmaceuticals IncVRTX29366
4.88%
Amgen IncAMGN38102
4.83%
Royalty Pharma PLCRPRX237665
4.77%
Biogen IncBIIB66296
4.77%
Regeneron Pharmaceuticals IncREGN20169
4.50%
CareDx IncCDNA324147
4.49%
Gilead Sciences IncGILD95721
4.14%
United Therapeutics CorpUTHR22127
4.05%
Alnylam Pharmaceuticals IncALNY43319
3.67%
Bio-Techne CorpTECH145555
3.44%
Protagonist Therapeutics IncPTGX69833
3.26%
Veracyte IncVCYT157932
3.25%
Vericel CorpVCEL199662
3.14%
Illumina IncILMN48078
3.12%
Repligen CorpRGEN60614
2.95%
Incyte CorpINCY71907
2.94%
ACADIA Pharmaceuticals IncACAD328418
2.83%
PTC Therapeutics IncPTCT103212
2.83%
QIAGEN NVQGEN196461.3786
2.76%
Halozyme Therapeutics IncHALO101605
2.75%
BioMarin Pharmaceutical IncBMRN132040
2.73%
Exelixis IncEXEL139699
2.68%
Neurocrine Biosciences IncNBIX44836
2.68%
BioCryst Pharmaceuticals IncBCRX824338
2.61%
Collegium Pharmaceutical IncCOLL206694
2.52%
Sarepta Therapeutics IncSRPT418846
2.45%
AnaptysBio IncANAB120862
2.03%
Ardelyx IncARDX1117146
2.03%
Omeros CorpOMER599328
1.84%
Legend Biotech CorpLEGN236443
0.08%
Invesco Government & Agency PortfolioAGPXX229088.83
0.00%
USD Pending Dividends0
0.00%
CASH & EQUIVALENTSUSD-4524.21